[1] 吴波,付文政.胃癌的东西方流行病学调查综述[J].临床误诊误治,2007,20(3):9-12. [2] Aquino PF.Are gastric cancer resection margin proteomic profiles more similar to those from control or tumors[J]?J Protemoe Res,2012,11(12):5836-5842. [3] 唐林,陈巍魏,管晓翔.AJCC第8版乳腺癌分期系统更新的解读[J].临床肿瘤学杂志,2017,22(11):1038-1040. [4] 孙曦,孙刚.内镜在胃癌筛查的应用和价值[J].临床内科杂志,2014,31(11):725-727. [5] Ikeda A, Nishiumi S, Shinohara M,et al.Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer[J].Biomed Chromatogr,2012,26(5):548-558. [6] Mikami T, Aoki M, Kimura T,et al.The application of mass spectrometry to proteomics and metabolomics in biomarker discovery and drug development[J].Curr Mol Phamacol,2012,5(2):301-316. [7] 周芬芳.氨基酸转运体L型氨基酸转运载体1在肿瘤中的研究进展[J].中华实验外科杂志,2016,33(2):550-552. [8] Zhang J, Bowers J, Liu L,et al. Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods [J].PLoS One, 2012, 7: e30181. [9] Mondanelli G, Ugel S, Grohmann U,et al.The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDO[J].Curr Opin Pharmacol,2017, 35: 30-39. [10] Manig F, Kuhne K, Von Neubeck C,et al.The why and how of amino acid analytics in cancer diagnostics and therapy[J].J Biotechnol,2017, 242: 30-54. [11] 刘树业,李娴,王素梅.肝癌患者血清氨基酸水平变化及意义[J].山东医药,2011,51(7):62-63. [12] 马延磊.基于液相色谱-质谱联用的结直肠癌代谢组模式特征性研究[J].中华胃肠外科杂志,2009,12(4):386-390.
2020, Vol. 37 
